Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Melanoma × TP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Recurrence 1 Pathologic Complete Response 1 Neoplasm Metastasis 1 Melanoma 1 Lymphatic Metastasis 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1

Interventions

Nivolumab 21 pembrolizumab 16 Ipilimumab 12 Temozolomide 10 toripalimab 8 Blood Specimen Collection 7 Biopsy 7 Dacarbazine 6 Cyclophosphamide 6 trametinib 5 fludarabine 5 dabrafenib 5 camrelizumab 5 atezolizumab 5 durvalumab 4 Interleukin-2 4 Injections 4 Chemotherapy, Adjuvant 4 palbociclib 3 binimetinib 3 apatinib 3 aldesleukin 3 Sorafenib 3 Introns 3 Gene Expression Profiling 3 Cisplatin 3 Carboplatin 3 Canvaxin 3 Bevacizumab 3 tremelimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡